A new review found as many as 45% of Type 2 diabetics are suffering multiple deficiencies in vitamins, minerals and ...

Nearly half of Type 2 diabetes patients suffer from micronutrient deficiencies, with vitamin D and magnesium being the most ...

Vitamin D, magnesium, and B12 deficiencies were common among people with type 2 diabetes according to new research.

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

According to a review of hospital-based cross-sectional studies, almost half the type 2 diabetes population is micronutrient ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Micronutrient deficiencies commonly occur in individuals with type 2 diabetes, according to a systematic review and ...

Novo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk ...

The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, ...

Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney ...

Managing type 2 diabetes involves complex treatment, workload, and costs that impose a significant burden on individuals, ...